CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-20 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +5,143,248 | 5,143,248 | ||
| 2025-02-20 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +3,428,832 | 3,428,832 | ||
| 2025-01-17 | Rawcliffe Adrian Chief Executive Officer | Sale | −30,601 | $0.58 | $18K | 44,327 |
| 2025-01-15 | Rawcliffe Adrian Chief Executive Officer | Sale | −29,096 | $0.57 | $17K | 41,582 |
| 2025-01-13 | Rawcliffe Adrian Chief Executive Officer | Sale | −12,539 | $0.59 | $7K | 17,801 |
| 2025-01-13 | Rawcliffe Adrian Chief Executive Officer | Sale | −17,934 | $0.59 | $11K | 25,711 |
| 2024-01-17 | Rawcliffe Adrian Chief Executive Officer | Sale | −30,080 | $0.67 | $20K | 44,848 |
| 2024-01-16 | Rawcliffe Adrian Chief Executive Officer | Sale | −9,304 | $0.79 | $7K | 14,104 |
| 2024-01-15 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +7,633,296 | 7,633,296 | ||
| 2024-01-15 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,696,272 | 1,696,272 | ||
| 2024-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −17,257 | $0.85 | $15K | 26,388 |
| 2024-01-11 | Rawcliffe Adrian Chief Executive Officer | Sale | −11,945 | $0.84 | $10K | 18,395 |
| 2023-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,403 | $0.78 | $2K | 3,449 |
| 2023-06-27 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,333 | $0.92 | $2K | 3,519 |
| 2023-01-17 | Rawcliffe Adrian Chief Executive Officer | Sale | −10,057 | $1.86 | $19K | 13,351 |
| 2023-01-17 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +4,690,224 | 4,690,224 | ||
| 2023-01-17 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,798,272 | 1,798,272 | ||
| 2023-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −18,763 | $1.71 | $32K | 24,882 |
| 2023-01-11 | Rawcliffe Adrian Chief Executive Officer | Sale | −13,042 | $1.75 | $23K | 17,298 |
| 2023-01-04 | Rawcliffe Adrian Chief Executive Officer | Sale | −5,073 | $1.69 | $9K | 6,631 |
Page 1 of 3 · 53 trades